Compound Name (alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM21221
| 94 | 1 | 0 | 4 | 0 | 0 | 0 | 0 | - 5-hydroxytryptamine receptor 2A
- 5-hydroxytryptamine receptor 2C
- ADORA1
- ADORA3
- Adenosine A1 receptor
- Adenosine A2a receptor
- Adenosine A3 receptor
- Adenosine Receptors A2a (A2a)
- Adenosine receptor
- Adenosine receptor A1
- Adenosine receptor A1/Alpha-2A adrenergic receptor
- Adenosine receptor A2
- Adenosine receptor A2a and A3
- Adenosine receptor A3
- Adenosine receptors; A1 & A2a
- Equilibrative nucleoside transporter 1
- Peroxisome proliferator-activated receptor
- Peroxisome proliferator-activated receptor delta
- Serotonin receptor (2b and 2c)
| - (2S,3S,4R,5R)-5-(2-chloro-6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-3,4-dihydroxy-N-methyloxolane-2-carboxamide
- 2-Cl-IB-MECA
- 2-chloro-N6-(3-iodobenzyl)adenosine-5-N-methylcarboxamide
- C-IBzA-MU
- C1-IB-MECA
- CHEMBL431733
- CI-IB-MECA
- Cl-IB-MECA
|
BDBM26739
| 46 | 51 | 0 | 2 | 0 | 0 | 0 | 0 | - 5-Hydroxytryptamine receptor 6 (5-HT6)
- 5-Hydroxytryptamine receptor 7 (5-HT7)
- 5-hydroxytryptamine receptor 1A (5-HT1A)
- 5-hydroxytryptamine receptor 1B
- 5-hydroxytryptamine receptor 1D
- 5-hydroxytryptamine receptor 2A
- 5-hydroxytryptamine receptor 3A
- ADRB2
- Adrenergic alpha1B
- Adrenergic receptor beta
- Alpha-1A adrenergic receptor
- Alpha-2A adrenergic receptor
- Alpha-2B adrenergic receptor
- Alpha-2C adrenergic receptor
- Anandamide amidohydrolase
- CHRM5
- Cannabinoid receptor 1
- Cannabinoid receptor 2
- Cholinergic, Nicotinic Alpha3Beta2
- Cyclooxygenase
- D(1A) dopamine receptor
- D(2) dopamine receptor
- Dopamine D5 receptor
- Dopamine receptor
- Dopamine receptors; D2 & D4
- Fatty-acid amide hydrolase 1
- Histamine H1 receptor
- Histamine H2 Receptor
- Kappa-type opioid receptor
- Monoamine transporters; serotonin & dopamine
- Mu-type opioid receptor
- Muscarinic acetylcholine receptor M1
- Muscarinic acetylcholine receptor M2
- Muscarinic acetylcholine receptor M3
- Muscarinic acetylcholine receptor M4
- Neuronal acetylcholine receptor subunit alpha-4
- Neuronal acetylcholine receptor; alpha2/beta2
- P-glycoprotein 1
- Potassium voltage-gated channel subfamily H member 2
- Prostaglandin G/H synthase (cyclooxygenase)
- Serotonin (5-HT) receptor
- Serotonin receptor 2a and 2c (5HT2A and 5HT2C)
- Sigma non-opioid intracellular receptor 1
- Sigma-2
- Sodium-dependent noradrenaline transporter
- Transient receptor potential cation channel subfamily A member 1
| - 3-(3-carbamoylphenyl)phenyl N-cyclohexylcarbamate
- CHEMBL184238
- URB 597
- URB-597
- URB597
- US9187413, 1a (URB597)
|
BDBM317013
| 0 | 99 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 1A2
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6
- Cytochrome P450 3A
- Epidermal growth factor receptor(L858R, T790M)
- RAF proto-oncogene serine/threonine-protein kinase (RAF-1)
- bRAF serine/threonine protein kinase
| - US9617267, Compound P-2001
- US9617267, Compound P-2002
- US9617267, Compound P-2003
- US9617267, Compound P-2004
- US9617267, Compound P-2005
- US9617267, Compound P-2006
- US9617267, Compound P-2007
- US9617267, Compound P-2008
- US9617267, Compound P-2012
- US9617267, Compound P-2013
- US9617267, Compound P-2015
|
BDBM50031467
| 8 | 91 | 0 | 0 | 0 | 0 | 0 | 0 | - Cell surface glycoprotein MUC18
- D-Amino Acid Oxidase (DAAO)
- D-amino-acid oxidase
- Polyphenol oxidase (PPO)
- Tyrosinase
| - 5-HYDROXY-2-(HYDROXYMETHYL)-4H-PYRAN-4-ONE
- 5-Hydroxy-2-hydroxymethyl-pyran-4-one
- CHEMBL287556
- Kojic Acid
- US9422261, Kojic acid
- US9682910, kojic acid
|
BDBM50122654
| 1 | 98 | 0 | 0 | 0 | 0 | 0 | 0 | - Gonadotropin releasing hormone 1 (GnRHR1)
- Gonadotropin-releasing hormone receptor
| - 1-(4-(1-(2,6-difluorobenzyl)-5-((benzyl(methyl)amino)methyl)-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea
- 1-{4-[5-[(Benzyl-methyl-amino)-methyl]-1-(2,6-difluoro-benzyl)-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydro-thieno[2,3-d]pyrimidin-6-yl]-phenyl}-3-methoxy-urea
- CHEMBL22055
- N-[4-(3-phenyl-5-(N-benzyl-N-methyl-aminomethyl)-1-(2,6-difluorobenzyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl]-N'-methoxyurea
- TAK-013
- sufugolix
|
BDBM50139013
| 49 | 40 | 0 | 10 | 0 | 0 | 0 | 0 | - Delta-type opioid receptor
- Kappa-type opioid receptor
- Mu-opioid receptor
- Mu-type opioid receptor
- Neurokinin 1 receptor
- Nociceptin/mu opioid receptor
- Opioid receptors; mu & delta
- Uncharacterized protein
- mu/kappa opioid receptor
| - (S)-1-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic acid [(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide
- (S)-N-((S)-1-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-1-((S)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamide
- 1-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylicacid[1-((S)-(S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide
- CHEMBL333357
- H-Tyr-Pro-Phe-Phe-NH2
- Tyr-Pro-Phe-Phe-NH2
- endomorphin-2
|